Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
September 26, 2022 at 11:11 AM EDT
Pfizer and German partner BioNTech said Monday they're seeking Food and Drug Administration authorization for their omicron-targeting bivalent vaccine for use in children aged 5 to 11 years of age.
